We're proud to invest in Ikerian as they enhance their AI-driven RetinAI Discovery platform and Discovery CONNECT?. Through THINC Ventures, we're empowering early to growth-stage startups who are working to accelerate?our mission of Healthcare from the Eye?.?
We are thrilled to announce the first close of our USD 8M (CHF 6.73M) Series B funding led by Sanoptis, with continued support from existing investors including THINC Ventures (Topcon Healthcare Inc.), Zürcher Kantonalbank, and Verve Ventures. This funding will accelerate the development and commercialization of ?????????????? ???????????????????? and ?????????????????? ????????????????, enabling seamless data connectivity and AI-driven insights in ophthalmology, optometry and beyond. Through our partnership with Sanoptis, we are bringing cutting-edge AI solutions to hundreds of clinics across Europe, enhancing patient care and data workflows in the clinic. Our journey doesn’t stop here! Through Ikerian we are expanding our capabilities into new therapeutic areas, including neurodegenerative disorders and rare diseases, leveraging real-world evidence (RWE) and AI to support better decision-making in healthcare. A big thank you to our partners, investors, and the incredible Ikerian / Retinai team for making this milestone possible! Learn more ?? https://lnkd.in/ei8x7-w6 ?? Stay tuned for more updates as we continue to revolutionize healthcare through data and AI?? #SeriesB #HealthTech #AIinHealthcare #Ophthalmology #DataDriven #HealthcareInnovation #eyecare #machinelearning #artificialintelligence #innovation